Serum epiplakin levels might be a suitable non-invasive diagnostic method as an adjunct to urinary cytology and cystoscopy for diagnosis of bladder cancer once proven in a prospective cohort study. This evidence concerns the gene EPPK1 and urinary bladder carcinoma.